Guggenheim Capital LLC Maravai Lifesciences Holdings, Inc. Transaction History
Guggenheim Capital LLC
- $13.9 Billion
- Q2 2024
A detailed history of Guggenheim Capital LLC transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 12,637 shares of MRVI stock, worth $105,013. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,637
Previous 11,273
12.1%
Holding current value
$105,013
Previous $97,000
7.22%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding MRVI
# of Institutions
221Shares Held
124MCall Options Held
176KPut Options Held
2.2K-
12 West Capital Management LP New York, NY13.2MShares$110 Million9.86% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$89.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$80.8 Million0.0% of portfolio
-
Braidwell LP Stamford, CT9.02MShares$75 Million2.03% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.97MShares$49.6 Million0.02% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $1.09B
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...